Clinical Trial Update: Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of PG110 in patients with knee osteoarthritis pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• PG110

Snippet

Sponsor: Abbott | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED